| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |